Surgery Partners, Inc.

NASDAQ:SGRY

Medical - Care Facilities

Healthcare
$26.96 +0.39%

+$0.06 today

Market cap
$3.53B
Beta
1.95
P/E (TTM)
-24.1
EPS (TTM)
-$0.59
52W Low $11.41High $24.10

Volume 3.24M

Average 1.36M

SGRY Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Surgery Partners, Inc.NASDAQ: SGRY

Stock-Based Compensation · Q3 FY2026 · quarter ended Sep 2026

Stock-based compensation growth accelerates

Q3 FY2026 stock-based compensation of $6M rose 130.8% year over year, ahead of the -83.6% change in trailing-twelve-month stock-based compensation. Over 3 fiscal years it compounded at -7.0% a year.

Context

  • Stock-based compensation amounted to 0.4% of revenue in FY2025, down 0.6 pp from a year earlier.
  • Stock-based compensation increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +130.8% holds above the trailing-twelve-month pace of -83.6%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$6M+203.4% QoQ
Last fiscal yearDec 2025
$14.8M-55.6% YoY
LTMSep 2026
$3.8M-83.6% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+130.8%——
1 year-55.6%——
3-year CAGR-7.0%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
14.8M USD
Year-over-year change
-55.6%
4-year CAGR
-4.0%

Stock-Based Compensation vs competitors

How SGRY compares with its peers on the latest reported figures

  • SGRY's LTM Sep 2026 stock-based compensation of $3.8M is the 5th largest of the 7 companies compared; the peer median is $38.83M.
  • Its year-over-year change of -83.6% is the 5th highest of 6, against a peer median of +22.2%.
  • Stock-based compensation amounts to 0.1% of revenue for SGRY, versus a peer median of 0.3%.
SGRY Competitors Peer median
Stock-Based Compensation for SGRY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
THCTenet Healthcare CorporationLTM Jun 2026$88M +22.2%+22.9%0.4%
NUTXNutex Health, Inc.LTM Mar 2026$85.45M +62.2%+751.4%9.7%
UHSUniversal Health Services, Inc.LTM Jun 2026$48.37M -51.1%+3.9%0.3%
ARDTArdent Health Partners, LLCLTM Mar 2026$29.29M +216.2%+300.6%0.5%
SGRYSurgery Partners, Inc.LTM Sep 2026$3.8M -83.6%-7.0%0.1%
CYHCommunity Health Systems, Inc.LTM Mar 2026$3M ——0.0%
HCAHCA Healthcare, Inc.LTM Jun 2026$0 -100.0%—0.0%
Peer median (excluding SGRY) $38.83M+22.2%+161.8%0.3%

Competitors are the stored peer set for SGRY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income70.7M87M135.3M12.5M98.9M
Depreciation & Amortization98.8M114.8M118.1M152.6M176M
Deferred Income Tax8.9M21.9M(1.7M)131.5M16.7M
Stock-Based Compensation17.4M18.4M17.7M33.3M14.8M
Change in Working Capital(149.1M)(102.3M)(62.3M)(118.9M)(110.4M)
Accounts Receivables(32.1M)(35.3M)(47.2M)(72.1M)(53.8M)
Inventory00000
Accounts Payables00000
Other Working Capital(117M)(67M)(15.1M)(46.8M)(56.6M)
Other Non-Cash Items40.4M19M86.7M89.1M78.3M
Operating Cash Flow87.1M158.8M293.8M300.1M274.3M
Capital Expenditures(57.6M)(80.6M)(88.8M)(90.4M)(78.7M)
Acquisitions (Net)(280.4M)(228.7M)(128.9M)(378.8M)(162.1M)
Purchases of Investments000(1.7M)(13.3M)
Sales of Investments0004.6M0
Other Investing Activities6.3M1.4M(7.9M)(22.2M)7.5M
Investing Cash Flow(331.7M)(307.9M)(225.6M)(488.5M)(246.6M)
Debt Repayment(43.8M)(644.2M)19.5M450.4M158.7M
Common Stock Issued581.8M882.9M000
Common Stock Repurchased00000
Dividends Paid(5.1M)0000
Other Financing Activities(216.6M)(196.6M)(174.7M)(188.4M)(216M)
Financing Cash Flow316.3M42.1M(155.2M)262M(57.3M)
Effect of Forex Changes00000
Net Change in Cash71.7M(107M)(87M)73.6M(29.6M)
Free Cash Flow29.5M78.2M205M209.7M195.6M

Surgery Partners, Inc.

NASDAQ:SGRY

Intrinsic Alpha fair value

Locked

Current Price

$26.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.